Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

581
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
581
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

135
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
135
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

707
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
707
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

519
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
519
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Clinical and Molecular Genetic Risk Factors for Severe Familial Hypercholesterolemia.

Journal of lipid and atherosclerosis·2026
Same authorSame journal

Treatment Target Discovery From Vasculo-Protective Phenotypes.

Journal of lipid and atherosclerosis·2026
Same author

Effects of a spore-forming probiotic blend on bowel habits and physical well-being in adults with functional constipation: A randomized, double-blind, placebo-controlled trial.

PloS one·2026
Same author

Development of a Sex-Specific Prevalent Hypertension Discrimination Model in Korean Adults Using Genetic Risk Scores and Clinical Biomarkers: A Cross-Sectional Study.

Current issues in molecular biology·2026
Same author

Triglycerides and Hypertension in a Korean Population: An Individual-Level Mendelian Randomization Analysis.

Nutrients·2026
Same author

Diabetes-specific oral nutritional supplement for prediabetes improves postprandial glycemic responses: an open-label, crossover clinical trial.

Nutrition research and practice·2025
Same journal

Multidisciplinary Rescue for a Lethal Triad: Severe Hypertriglyceridemia, Necrotizing Pancreatitis, and Abdominal Compartment Syndrome in Pregnancy.

Journal of lipid and atherosclerosis·2026
Same journal

Association of Smoking Status and Urinary Cotinine Levels With Lipoprotein(a) in Korean Adults.

Journal of lipid and atherosclerosis·2026
Same journal

Molecular and Genetic Aspects of Lipid Metabolism Disorders and Potential Targets for Gene Therapy.

Journal of lipid and atherosclerosis·2026
Same journal

Sex Differences in the Diagnosis and Treatment of Japanese Patients With Familial Hypercholesterolemia: A Retrospective Cohort Study.

Journal of lipid and atherosclerosis·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

2024 KSoLA Consensus on Secondary Dyslipidemia.

Hoyoun Won1, Jae Hyun Bae2, Hyunjung Lim3,4

  • 1Cardiovascular-Arrhythmia Center, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

Journal of Lipid and Atherosclerosis
|October 2, 2024
PubMed
Summary
This summary is machine-generated.

Secondary causes of high cholesterol and triglycerides are common. Addressing these underlying issues before lipid-lowering therapy is crucial for effective treatment of secondary dyslipidemia.

Keywords:
DiagnosisDrug-related side effects and adverse reactionsFoodLipoproteinsMetabolism

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Related Experiment Videos

Last Updated: Jun 11, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.3K

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Secondary causes frequently contribute to elevated blood cholesterol and triglyceride levels.
  • Dyslipidemia management requires identification and treatment of these underlying causes.
  • Unhealthy diet, certain diseases, metabolic conditions, and medication side effects are major contributors.

Purpose of the Study:

  • To emphasize the importance of identifying and managing secondary causes of dyslipidemia.
  • To highlight the necessity of addressing secondary causes before initiating conventional lipid-lowering therapies.
  • To provide a framework for lipid management in patients with secondary dyslipidemia.

Main Methods:

  • Review of literature on secondary causes of dyslipidemia.
  • Analysis of clinical guidelines for lipid management.
  • Case study examples illustrating the impact of secondary causes.

Main Results:

  • Secondary causes are prevalent and significantly impact lipid profiles.
  • Effective management of secondary causes leads to improved lipid levels.
  • Timely intervention for secondary causes optimizes outcomes for lipid-lowering therapy.

Conclusions:

  • Correcting secondary causes is a prerequisite for successful dyslipidemia treatment.
  • Guideline-based lipid therapy should be implemented after addressing secondary factors.
  • Comprehensive management of dyslipidemia involves a two-step approach: addressing secondary causes followed by conventional therapy.